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Antithrombotic effect of grape seed proanthocyanidins
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Zunfu Ke, PhD, MD,a Ping Xu, MD,b Zhiqiang Zhong, PhD,c Xiaoxi Li, PhD, MD,a
and Shenming Wang, PhD, MD, FACS,a Guangzhou, Guangdong, and Guiyang, China
Objective: Proanthocyanidins are abundantly found in grape seeds and have been suggested to inhibit the pathogenesis of
systemic diseases. We investigated the antithrombotic effects of proanthocyanidins in a rat model of deep vein thrombosis
(DVT) and examined the underlying mechanisms.
Methods: DVT was induced in rat model by inferior vena cava (IVC) ligation. Grape seed proanthocyanidins extract (GSPE, 400
mg/kg/d)dissolved in saline (2mL)wasorally administered to the experimental rats.Control ratswere administrated saline (2mL)
only. The thrombiwere harvested andweighed. The IVCwas analyzed histologically and by transmission electronmicroscopy. The
cytokines interleukin (IL)-6, IL-8, and tumor necrosis factor- (TNF-) were detected by enzyme-linked immunosorbent assay.
Expression of cellular adhesion molecules (CAMs) in thrombi was examined byWestern blot.
Results: GSPE significantly reduced thrombus length and weight (P < .01) and protected the integrity of the
endothelium. GSPE inhibited thrombogenesis-promoting factors P-selectin, von Willebrand factor, and CAMs, and
promoted thrombogenesis-demoting factors CD34, vascular endothelial growth factor receptor-2, and ADAMTS13 (a
disintegrin and metalloproteinase with a thrombospondin type one motif, member 13). Compared with the control,
GSPE significantly lowered the cytokines IL-6 (74.19 13.86 vs 189.54 43.76 pg/mL; P< .01), IL-8 (80.71 21.42
vs 164.56  39.54 pg/mL; P < .01), and TNF- (43.11  17.58 vs 231.84  84.11 pg/mL; P < .01).
Conclusions: GSPE significantly inhibited the propagation of thrombus induced by IVC ligation in a rat model. The
antithrombotic properties of proanthocyanidins are likely to be directly associated with endothelial protection and
regeneration, platelet aggregation, and inhibition of inflammatory cell and thrombus adhesion. Thus, proanthocyanidins
may have a clinical application in DVT treatment. (J Vasc Surg 2011;53:743-53.)
Clinical Relevance:Themajor presenting symptoms of deep vein thrombosis (DVT) are pain, swelling, and sometimes intractable
venousulceration.Thesearemainly causedby intravenous thrombosisocclusionand local inflammatory reaction.Tworecent clinical
studies reported that the levels of inflammatory markers such as interleukin-6, intercellular adhesion molecule 1 (ICAM-1), and
C-reactive protein were associated with the development of postthrombotic syndrome (PTS). Our current results show that grape
seed proanthocyanidins extract (GSPE) inhibited interleukin-6 release and ICAM-1 expression, which may suggest that prompt
administration of GSPE is instrumental to thrombus clearance, removal of venous outflow obstruction, and attenuation of venous
endothelium loss in PTS. Clinically, oral anticoagulants, heparin, and urokinase/streptokinase regimens are routinely used for
treating DVT patients. These medicines are effective in correcting bloodstream stasis and hypercoagulable state; however, they are
unable to cure endothelium injury caused by preceding thrombus occlusion that induces endothelial inflammation, compression,
and hypoxia. This pathologymay contribute to the recurrence of DVT, PTS, and other complications. Therefore, it is necessary to
find a novel regimen that is effective and safe for the treatment of DVT. GSPEmay be such a promising candidate.
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flRecent studies reveal that proanthocyanidins are one of
the most important polyphenolic antioxidants present in
grape seeds.1,2 Potential therapeutic values of grape seed
proanthocyanidin extract (GSPE) are associated with its
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doi:10.1016/j.jvs.2010.09.017ntioxidant and anti-inflammatory properties.3-7 Several
tudies have suggested that proanthocyanidins may benefi-
ially affect endothelium injury, platelet aggregation, and
nflammation involved in the pathogenesis of systemic dis-
ases.5-9 However, the antithrombotic effects of GSPE on
enous thrombosis have not been reported yet.
The classic risk factors for deep vein thrombosis (DVT)
re described as Virchow’s triad—endothelium injury,
lood stasis, and hypercoagulability—which are closely as-
ociated with inflammation. Inflammation is important in
he formation and progress of DVT.10,11 The theory of
hrombotic inflammation resulting in endothelial injury
nd platelet aggregation has received more attention now-
days; however, the precise mechanisms are still unclear.
revious studies have suggested that prothrombotic in-
ammatory mediators, endothelium injury, and platelet
ggregation are important components in the pathogenesis
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March 2011744 Zhang et alof DVT.12-15 However, the endothelium protection and
regeneration has not yet drawn sufficient attention in the
field of DVT therapeutics.
The goal of present study was to determine whether
GSPE inhibits thrombogenesis in an inferior vena cava
(IVC) ligation-induced rat DVTmodel and to examine the
underlying mechanisms. We hypothesized that GSPE
would inhibit the propagation of thrombus induced by
IVC ligation, and a few lines of experimental evidence
support that the antithrombotic properties of GSPE are
directly associated with inhibition of inflammatory cell and
thrombus adhesion, endothelial cell proliferation signal
transduction, and endothelial progenitor cell-induced en-
dothelium regeneration. Our results may suggest that
GSPE is a promising candidate for clinical use in treatment
of DVT.
MATERIALS AND METHODS
This project was approved by the Animals Ethics Com-
mittees of Sun Yat-sen University.
Animal care. The study used 50male Sprague-Dawley
rats (weight, 280-330 g). The animals were kept in condi-
tions of 23  2°C temperature at 12-hour dark-light cycle
in the specified pathogen free animal house of the Central
Animal Laboratory, Sun Yat-sen University, Guangzhou,
China. The rats had free access to standard rat chow and
water.
Animal model operating procedures. Rats were ran-
domly divided into three groups: group A (control, n 
15), group B (GSPE-treated, n 25), and group C (sham-
operated, n  10). Each rat in these groups received an
operative procedure. DVT was induced in the rats of
groups A and B according to the previously described
method.10,16 Briefly, anesthesia was initiated and main-
tained by the combination of oxygen (0.5 L/min) and
isoflurane (1% to 4%), and all rats underwent laparotomy.
Rats in groups A and B underwent ligation of the IVC
below the renal veins and all visible side branches involved.
Consequent obstruction and stasis of the bloodstream re-
sulted in rapid IVC dilatation and thrombosis, and thrombi
were detected 24 hours. The remaining rats received a
sham operation, undergoing laparotomy and suturing, but
without infrarenal IVC ligation. The sham group was set to
obviate the operation-related traumatic effects.
Whole blood was collected from the caudal vein before
the operation and every 12 hours after. Thrombi harvested
from IVCwere gently washed by phosphate-buffered saline
(PBS) and weighed (with no vein walls and drops) at 1, 3,
5, 7, and 14 days in groups A and B. IVC tissues were
carefully dissected and removed from the area 1 to 2 mm
from the ligature for histologic analysis at 1, 3, and 5 days.
Serumwas obtained by centrifugation and stored at80°C
until use for biochemical andWestern blot analyses. All rats
were euthanized at various times up to 2 weeks.
GSPE administration. The rats in group A were in-
tragastrically administrated saline (2 mL) every 24 hours.
After IVC ligation, the group B rats received daily intragas-
tric administration of GSPE (400 mg/kg/d) dissolved in (aline (2 mL). The GSPE (sources: grape seed; ethanol
xtraction oligomeric proanthocyanidins B2 and B3; purity:
5%) was obtained from BAOXING Bio-technologies Co,
td, Guangzhou, China.
Morphologic examination. Vascular tissues were
xed with cold 2% paraformaldehyde and 2% glutaralde-
yde in 0.1M sodium cacodylate buffer (pH 7.4; Electron
icroscopy Sciences, Hatfield, Pa) at 4°C overnight. Tis-
ues were washed in sodium cacodylate buffer, rinsed with
istilled water, and trimmed into smaller pieces. IVC tissues
ere postfixed in 1% osmium tetroxide and potassium
errocyanide (Electron Microscopy Sciences, San Diego,
alif) to enhance membrane contrast.
After extensive rinsing with distilled water, tissues were
ehydrated in a graded series of ethanol and embedded in
raldite (Electron Microscopy Sciences). All specimens
ere cut into semithin sections of 0.5 to 1 m in thickness,
ounter-stained with toluidine blue/basic fuchsin stain,
nd examined using a Zeiss Light Microscope (Carl Zeiss,
ena, Germany). All ultrathin sections of 60 to 80 nm were
ollected on copper grids, doubled-stained with uranyl
cetate and lead citrate for 8 minutes each, and then viewed
nd photographed on a CM-10 transmission electron mi-
roscope (TEM; Philips Electronics, Mahwah, NJ).
Immunohistochemical staining. Vessel specimens
ere collected from experimental rats. Immunohistochem-
cal staining was performed on the paraffin-embedded tis-
ue sections (10 m) as described.10 Briefly, samples were
xed in formalin or snap-frozen and stored at 70°C.
ormalin-fixed tissues were embedded in paraffin, sec-
ioned, and stained with hematoxylin and eosin. For CD34,
ascular endothelial growth factor receptor-2 (VEGFR-2)
nd P-selectin localization, serial sections fixed in
araformaldehyde-lysine-periodate were incubated at 4°C
vernight with anti-CD34 (1:100; mouse monoclonal anti-
D34, Santa Cruz Biotechnology, Santa Cruz, Calif), anti-
EGFR-2 (1:100; mouse monoclonal anti-VEGFR-2, Ab-
am, Cambridge, Mass), and anti-P-selectin polyclonal
ntibody (1:100; goat anti-rat P-selectin, Santa Cruz Bio-
echnology). Sections were washed, and bound primary
ntibodies were detected by successive incubations with
ridging antibodies, peroxidase-antiperoxidase complexes
DAKO, Glostrup, Denmark), the substrate, diaminoben-
idine, and finally, counterstained with hematoxylin.
Immunofluorescence. Cryostat sections obtained
rom snap-frozen tissues were used for the localization of
on Willebrand factor (vWF) and ADAMTS13 (a disinteg-
in and metalloproteinase with a thrombospondin type one
otif, member 13). Specimens were stored at 80°C
efore immunofluorescence detection. Serial sections were
xed in 4% paraformaldehyde in PBS at 4°C. After three
ashes with PBS, the specimens were incubated with a
locking buffer (PBS, 0.5% Triton X-100, and 5% goat
erum) for 4 to 16 hours at 4°C. After removal of the
locking buffer, they were subsequently incubated with
nti-vWF (H-300) polyclonal antibody (1:100; rabbit anti-
at vWF, Santa Cruz Biotechnology) or anti-ADAMTS13
H-300) polyclonal antibody (1:100; rabbit anti-rat
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lectin-staining buffer (PBS, 1% Triton X-100, 0.1 mM
CaCl2, and 0.1 mM MnCl2) on a rotator. After three
washes with PBS, specimens were detected by successive
incubation with cyanine3/fluorescein isothiocyanate-
conjugated antirabbit immunoglobulin G (IgG).
Enzyme-linked immunosorbent assay. IL-6, IL-8,
and tumor necrosis factor (TNF)- in rat serum were
prepared by centrifugation at 800g for 15 minutes and
deproteinated. Concentrations of these inflammatory fac-
tors were determined by enzyme-linked immunosorbent
assay (ELISA) kits (Sigma-Aldrich, San Diego, Calif) using
matched antibody pairs, according to the manufacturer’s
instructions. Briefly, samples were added into 96-well plate,
incubated at room temperature for 2 hours, and then
washed three times with PBS.
After washing to remove the unbound molecules, sam-
ples were incubated with 3% bovine serum albumin to
block nonspecific binding for 30 minutes. These inflam-
matory markers were detected by incubation with rabbit
anti-rat monoclonal antibody for 1 hour, followed by an
additional 30 minutes of incubation with horseradish
peroxidase-conjugated goat antirabbit IgG. Positive
color was developed with o-phenylenediamine and de-
tected in a spectrophotometer (Bio-Rad Laboratories,
Hercules, Calif) at 450 nm.
Western immunoblotting. Protein was isolated from
thrombus lysed in a lysis buffer (50 mM Tri-HCl, 150 mM
NaCl, 1 mM ethylenediaminetetraacetic acid, 1% Nonidet
P-40, 1 mM Na3VO4, 1 mM phenylmethyl sulfonyl fluo-
ride, 1 mg/mL aprotinin, and leupeptin, at pH 7.4) for 20
minutes on ice. The lysates were centrifuged at 14,500 rpm
for 20 minutes at 4°C. The concentration of protein in
lysate was measured with a bicinchoninic acid kit (Pierce
Co). A 15-g protein lysate was subjected to electropho-
resis on 8% sodium dodecyl sulfate polyacrylamide gels to
detect vascular cell adhesion molecule (VCAM)-1 and in-
Fig 1. Grape seed proanthocyanidins extract (GSPE) re
(b) size increased and reached peak values at about days
in the GSPE group were significantly smaller than the co
size (weight in g/length in cm). **P  .01.tercellular cell adhesion molecule (ICAM)-1. 0The samples were then electroblotted onto nitrocellu-
ose paper. After blocking, blots were incubated with anti-
CAM-1 (1:500; rabbit anti-rat VCAM-1, Santa Cruz
iotechnology) and anti-ICAM-1 (1:500; mouse anti-rat
CAM-1, Santa Cruz Biotechnology) in PBS/Tween 20
or 2 hours at 37°C and then incubated with horseradish
eroxidase-conjugated anti-rabbit or anti-mouse IgG
KPL, Gaithersburg, Md) for 30 minutes. The expression
f VCAM-1 and ICAM-1 was determined using the en-
anced chemiluminescence kit (Amersham Pharmacia Bio-
ech, Piscataway, NJ), and chemiluminescence exposure
as detected by the filters of Kodak X-Omat films (Car-
stream Health Inc, Rochester, NY).
Statistical analysis. Data were reported as means 
E and were analyzed statistically by analysis of variance,
ndependent-samples t test, and linear correlation analysis
t certain time points and with appropriate controls using
PSS 15.0 software (SPSS Inc, Chicago, Ill). A value of P
05 was considered significant. All experiments were re-
eated at least three times to confirm reproducibility.
ESULTS
GSPE reduced thrombus formation after IVC
igation. Thrombi were formed by IVC ligation and col-
ected at 1, 3, 5, 7, and 14 days, and their sizes and weights
ere measured. In group A (control), the lengths of
hrombi increased from 0.17 0.04 cm (day 1) to 0.89 
.13 cm (day 14; Fig 1, a), and the weights increased from
.0078 0.0014 g (day 1) to 0.0531 0.0043 g (day 14;
ig 1, b). Thrombus size peaked at days 5 to 7 and there-
fter remained at a plateau. Stasis and trauma are two main
auses of DVT. In control rats, these factors triggered the
elease of prothrombotic molecules and cytokines, acti-
ated platelets, and induced endothelium injury, thus ac-
elerating the progress of thrombosis.
In the GSPE-treated group, lengths of the thrombi
veraged at 0.16  0.02 cm, significantly smaller than the
d thrombosis formation. The thrombus (a) length and
7. The longitudinal axis length and weight of thrombus
(since day 3); (c) GSPE significantly reduced thrombusduce
5 to
ntrol.51 0.08 cm for the control rats (P .01), and weights
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March 2011746 Zhang et alof the thrombi averaged 0.0027  0.0006 g, significantly
lighter than 0.0314  0.0046 g for the control rats (P 
.01). The index of weight (g)/length (cm) in the GSPE
group was significantly lower than in the control rats (P 
.01, Fig 1, c).
In addition, linear regression analysis revealed linear
correlations between thrombus weight and cytokine pro-
duction: IL-6 and thrombus weight (r 0.874, P .001),
IL-8 and thrombus weight (r  0.878, P  .001), and
TNF- and thrombus weight (r 0.919, P .001; Fig 2).
However, the linear correlations were not shown in the
GSPE group for IL-6 (r  0.005), IL-8 (r  0.029), and
TNF- (r  0.353).
Histologic analysis showed that IVC endothelium was
subjected to thrombi compression and adhesion, and fibrin
strands and platelet aggregates were attached to a grossly
intact vein wall, whereas these were not found in the GSPE
and sham group (Fig 3). Collectively, these results indicate
that the process of thrombogenesis is associated with in-
flammatory cytokine release and endothelium injury.
GSPE protected the integrity of the endothelium.
To further investigate the protective effects of GSPE on the
vein wall endothelium, we used a TEM to analyze endo-
thelial morphologic changes. Fig 4, a shows that prethrom-
botic vein wall endothelium had integrity and was smooth,
without leukocytes adhesion or infiltration. In contrast,
Fig 4, b shows that activated macrophages and monocytes
adhered to the endothelium after IVC ligation. Further-
more, the thrombotic compression and inflammation re-
sulted in endothelial cell necrosis and apoptosis (Fig 4, c)
and subendothelial extracellular matrix exposure and con-
tact with blood cells (Fig 4, d), thus destroying the integrity
of endothelium (Fig 4, e). Leukocyte recruitment exacer-
bated the development of thrombosis, and inflammation-
activated leukocytes released molecules to induce cell ad-
hesion (Fig 4 g). In the GSPE-treated group, however, the
cell-cell junction was closed, without leukocyte adhesion or
infiltration (Fig 4, h), suggesting that the integrity of the
endothelium was protected by the GSPE treatment. These
results indicate that thrombosis induces endothelium loss
by way of inflammation but that GSPE protected the
integrity of the endothelium by protecting endothelial cells
from inflammatory attack.
GSPE increased CD34 and VEGFR-2 expression in
the endothelium. To assess the role of GSPE in endothe-
lial protection and regeneration, expression of CD34 and
VEGFR-2 was determined by immunohistochemical stain-
ing. The expression of CD34 and VEGFR-2 in the endo-
thelium in the GSPE-treated group was significantly higher
than in the control group at day 3, when thrombosis-
induced endothelium loss was substantial (P .05; Fig 5).
The findings of histologic staining are in accord with the
TEM microscopic endothelial observation (Fig 4). The
results indicate that GSPE may induce endothelial cell
proliferation and endothelial progenitor cell repair by in-
creasing the CD34 and VEGFR-2 expression in the endo-
thelium. aGSPE inhibited P-selectin expression. P-selectin ex-
ression in the control group reached a peak at day 3, and
he upregulation of P-selectin localized prothrombotic mi-
roparticles to the area of stasis and promoted thrombo-
enesis (Fig 6). In addition, we observed that leukocyte
ecruitment was associated with high-P-selectin–stained
rea. In contrast, the expression of P-selectin was reduced
ignificantly (P  .05) in the GSPE-treated group com-
ared with the control group. These data demonstrated
hat GSPE reduced P-selectin expression to exert inhibitory
ffects on leukocyte recruitment and thrombosis.
GSPE downregulated vWF and upregulated
DAMTS13. We first tested whether GSPE affects the
xpression of vWF and ADAMTS13 by determining the
xtent to which vWF and ADAMTS13 localize after IVC
igation. Fluorescence staining displayed that vWF expres-
ion at day 1 was highly expressed in both the endothelium
nd thrombus in the control group (Fig 7, e) but was much
ownregulated in the GSPE-treated group (Fig 7, h). In
ontrast, the expression of ADAMTS13 in the GSPE-
reated group (Fig 7, i) was higher than in the control
roup (Fig 7, f). These results suggest that GSPE may
nhibit thrombogenesis by downregulating vWF expression
nd upregulating ADAMTS13 at the early stage of throm-
osis.
GSPE reduced IL-6, IL-8, and TNF- production.
revious studies suggest that IL-6, IL-8, and TNF- con-
ribute to the formation of thrombosis,13,14,17 especially in
he acute phase. We performed ELISA to determine
hether GSPE affects the release of these cytokines and
ound that the levels of IL-6, IL-8, and TNF- were all
arkedly elevated after the laparotomies, with and without
VC ligation. The increased cytokine production correlated
ith the weight of thrombosis (Fig 2). However, the cyto-
ine levels in the GSPE group were lower than the control:
L-6, 74.19  13.86 vs 189.54  43.76 pg/mL (P  .01);
L-8, 80.71  21.42 vs 164.56  39.54 pg/mL (P  .01);
nd TNF-, 43.11 17.58 vs 231.84 84.11 pg/mL (P
01). The levels of IL-6, IL-8, and TNF- all started to
ncrease at the early stage of thrombosis; however, GSPE
reatment markedly reduced these cytokines’ release.
GSPE reduced the VCAM-1 and ICAM-1 expres-
ion in thrombus. VCAM-1 and ICAM-1 contribute to
he congregation of inflammatory cells, platelet, and endo-
helial cells, so we examined whether GSPE affects the
xpression of these CAMs. Western blot analysis displayed
hat VCAM-1 and ICAM-1 expressions in the thrombi of
he GSPE group were significantly lower than in the con-
rol group (P  .01, Fig 8). These results indicate that
SPE inhibited the adhesion of thrombus to vessel wall by
ecreasing the VCAM-1 and ICAM-1 expression.
ISCUSSION
In the present study, we demonstrated that thrombo-
enesis occurred after IVC ligation in a rat model, which
nvolves endothelium injury, upregulation of vWF, CAMs,
nd inflammatory cytokines, as well as platelet aggregation
nd fibrin strand formation. We also found that GSPE
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Volume 53, Number 3 Zhang et al 747Fig 2. The thrombus weight has a linear correlation with the
cytokine production of (a) interleukin (IL)-6 (r  0.874), (b)
IL-8 (r  0.878); and (c) tumor necrosis factor (TNF)- (r 
0.919), but this was not shown in the grape seed proanthocyani-
dins extract (GSPE) group (IL-6, r  0.005; IL-8, r  0.029;
TNF-, r  0.353). sig 3. Mature thrombi (TH) were detected by hematoxylin and
osin staining in paraffin sections of inferior vena cava (IVC) biopsy
pecimens at day 3 after IVC ligation. Thrombi compression and
dhesion, fibrin strands, and platelet aggregates were observed to
ttach to a grossly intact vein wall (a, b). However, these were not
ound in the grape seed proanthocyanidins extract (GSPE) (c) and
ham group (d) (original magnification 200).
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March 2011748 Zhang et alreduced thrombus formation by maintaining the endothe-
lium integrity, increasing the expression of CD34,
VEGFR-2, and ADAMTS13, decreasing the expression of
P-selectin, VCAM-1, ICAM-1, and vWF expression, and
reducing the release of IL-6, IL-8, and TNF-. These new
data highlight the antithrombotic effects of GSPE through
protecting the endothelium, inhibiting platelet aggrega-
tion, and reducing the release of prothrombotic inflamma-
tory mediators.
In the preliminary study, bleeding time was significantly
prolonged when GSPE (400 mg/kg) was used (data not
Fig 4. Analysis of specimens by transmission electron m
magnification 6600); (b) after inferior vena cava ligati
day 1 (original magnification 5200); (c) endothelial
subendothelial extracellular matrix exposure and conta
integrity of endothelium was destroyed in the control g
genesis at day 1 (original magnification 5200); (g) an
molecules to induce the cell adhesion (original magnifi
extract maintained the integrity of endothelium at day 5
and infiltration (original magnification 5200). EC, En
phages/monocytes; RBC, red blood cell; Th, thrombi; vshown). For the sake of preventing bleeding in the preopera- aive period, we used the lower dose of GSPE (250-300 mg/
g) for the preadministration and maintenance dosage, and
his had the similar antithrombotic effect as the larger dose of
SPE (400mg/kg) administration sooner after IVC ligation.
o bleeding complications or death from bleeding occurred
n the rats in the present study. This suggests that GSPE could
e possibly used before (prevention) and after (therapeuti-
ally) thrombosis: the lower dosage could be used for preven-
ion and higher dosage for therapeutic effect.
To our knowledge, this is the first report investigating the
otential for GSPE administration to inhibit thrombus prop-
ope: (a) prethrombotic vein wall endothelium (original
flammation cell migration, adhesion, and infiltration at
ecrosis at day 3 (original magnification 11500); (d)
th blood cell (original magnification 8900); (e) the
at day 5 (original magnification 3900); (f) thrombo-
ted mononuclear macrophage releases cellular adhesion
5200) on day 3; (h) grape seed proanthocyanidins
the cell-cell junction closed without leukocyte adhesion
elial cell; EC(n), necrotic EC; M, mononuclear macro-
in wall.icrosc
on, in
cell n
ct wi
roup
activa
cation
, and
dothgation in a ratmodel. Actually, the thrombi did not comeout
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Volume 53, Number 3 Zhang et al 749s a regular cylinder. It could be argued that the handmade
easurementwe used does not reflect the true size of the clot.
evertheless, we found the clots in theGSPE groupwere two
o three times smaller than in the control group after day 3, so
e just compared the size of thrombus between the control
nd GSPE group by weight, longitudinal axis length, and
eight/length index. We observed that the progress of ve-
ous thrombosis was accompanied with endothelial cell de-
udation and leukocyte recruitment, consistent with previous
eports.18,19
During the acute phase of thrombogenesis, vWF is
eleased from endothelial cells, and platelets are thus acti-
ated. We also showed that P-selectin expression, leukocyte
ecruitment, and platelet aggregation significantly in-
reased in the control group. P-selectin has been found
pregulated in the vein wall as early as 6 hours after throm-
us induction.20 Interactions of P-selectin and its receptor
-selectin glycoprotein ligand-1 can stimulate the produc-
ion of thrombogenic microparticles from leukocytes, par-
icularly monocytes, along with platelets and endothelial
ells.15,21 Previous reports12-15 and the present study both
howed that an increase in the blood level of inflammation
ediators, such as CAMs and cytokines, may recruit leuko-
ytes, trigger platelet aggregation, induce fibrin strand
ormation, and exacerbate endothelium injury. The initial
apture of flowing platelets is mediated by the interaction of
WF and its receptor,13 and then CAMs allow leukocyte
ransmigration. P-selectin is also integrally involved in
hrombosis.15 On the other hand, thrombus sticks to the
ndothelium, causing compression, hypoxia, and inflam-
ation, which induces endothelial cell damage. At the site
f endothelium injury, activated platelets contact with the
ubendothelial extracellular matrix, triggering the forma-
ion of a hemostatic plug.However, prothrombotic factors,
uch as vWF, P-selectin, ICAM-1, and VCAM-1, were
ignificantly reduced when GSPE was administrated, ac-
ompanied with a reduction of thrombus formation.
tained in the grape seed proanthocyanidins extract (GSPE) group
t day 3, indicating the maintenance of the endothelium (original
agnification 200). i, j, VEGFR-2 expression in the control
pecimens was negatively stained on the major part of the endo-
helium but weakly positive at the site of the endothelium without
hrombus or leukocyte adhesion on day 3 (original magnification
200). k, l, The positively-stained areas were detected at the
ndothelium in GSPE group specimens at day 3 (original magni-
cation 200). m, The bar chart representing the percentage of
D34 stained at the endothelium shows that GSPE significantly
ncreased CD34 expression compared with control (P  .05). n,
he two bars representing the expression of VEGFR-2 in control
nd GSPE treatment show that the VEGFR2 expression in the
SPE treatment group is significantly higher than that of control,
alculated by the staining area/total area of the inferior vena cava
ndothelium (P  .05). The solid line arrows point to the positive
taining area; the dotted line arrows point to the negative staining
rea. TH, thrombus; vw, vein wall. *P  .05. 100: a, c, e, g, i,Fig 5. CD34 and vascular endothelial growth factor (VEGFR)-2
expression in the endothelium. CD34 (a, b) and VEGFR2 (g, h)
staining in the endothelium of sham group are shown as above. Repre-
sentative photomicrographs of immunohistochemistry-stained paraffin
sections of vein biopsy specimens are shown. c, d,TheCD34 expression
of endothelium incontrolgroupatday3 showsnegativeorweak staining
in the endothelium in the control, representing an endothelium loss ,
;/200: b, d, f, h, j, l.
c
f
n
m
d
p
w
a
m
p
t
p
w
wall.
JOURNAL OF VASCULAR SURGERY
March 2011750 Zhang et alA strong link has been reported between venous
thromboembolism and arterial thrombosis that is repre-
sented by endothelial dysfunction and endothelium
loss.22,23 Hence, maintaining the normal endothelial func-
tions and integrity of the endothelium is crucial in the
prevention and treatment of thrombosis. Here, we show
that the adhesion of inflammatory cells and thrombus to
the endothelial cells causes endothelium loss (Figs 3 and 4,
b, c, d, and e). In contrast, GSPE restored a healthy endo-
thelium by inhibiting inflammatory cytokines and CAMs
release (Fig 6, c, d; and Fig 8) at the early stage of throm-
bogenesis.
CD34 is a glycoprotein expressed on the surface of
Fig 6. Representative photomicrographs of immunohis
show P-selectin expression in the endothelium and plate
higher than in the (c, d) grape seed proanthocyanidin
thrombus and endothelial cells. At the site of high P-selec
expression is shown in the sham group. f, The bar chart sh
the staining area/total area of the IVC endothelium (P
strongly positive luminal area. TH, Thrombus; vw, veinendothelial progenitor cells and small-vessel endothelial pells.24 VEGFR-2 is a member of a receptor tyrosine kinase
amily whose activation plays an essential role in a large
umber of biologic processes such as embryonic develop-
ent, wound healing, cell proliferation, migration, and
ifferentiation.25 It has been suggested that endothelial
rogenitor cells (CD34/VEGFR-2) bind platelets by
ay of CD62P and inhibit platelet activation, aggregation,
dhesion to collagen, and thrombus formation.26 Further-
ore, VEGFR-2 mediates the endothelial cellular signal
athways, which is important in regulating vascular endo-
helial function and promoting vascular endothelial cell
roliferation and antithrombosis.27,28 This is consistent
ith our data showing that GSPE mediates endothelial
mistry-stained paraffin sections of vein biopsy specimens
xpression of P-selectin in (a, b) the control group was
act (GSPE) group at day 3, particularly in the area of
pression, leukocyte recruitment can be seen. e, P-selectin
hat GSPE decreased P-selectin expression, calculated by
Arrows point to the endothelium; triangles point to the
*P  .05. 100: a, c, e;/200: b, d.toche
lets. E
s extr
tin ex
ows t
.05).rotection and regeneration by increasing the expression of
t
l
p
b
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cells originated from remains to be ascertained.
The antithrombotic properties of GSPE should be as-
cribed to platelet antiaggregation induced by an increase of
ADAMTS13 expression, a decrease of vWF and CAMs
expression, and a reduced release of inflammatory cytokines
at the early stage of thrombosis. It is known that vWF
promotes adhesion of endothelial cells to the vessel wall and
thrombogenesis.29,30 ADAMTS13 can make a precise cut
in the specific peptide-bond site of vWF.31,32 We found
that vWF releases at the acute phase of thrombosis and
activates platelet aggregation to the site of endothelium
Fig 7. Expression is shown of von Willebrandt factor (
with a thrombospondin type 1 motif, member 13) in c
group, and (g, h, i) grape seed proanthocyanidins extra
endotheliumwas weakly stained. After inferior vena cava l
at day 1. e, Endothelium and thrombus were both stron
was weaker than the control. On the contrary, the expres
in the (i) GSPE group. Black arrows point to the endothe
White arrows point to the prethrombotic endothelium. Bl
group. Pink arrows point to the postthrombotic endothe
a, b, c, e, g, h, i;/200: d, f.injury, similar to the previous studies.33 Our data suggested ahat GSPE upregulated the ADAMTS13-mediated proteo-
ytic cleavage that is essential to reducing the size of vWF
olymers so that they remain functional enough to stop
leeding but not so sticky that they cause unwanted throm-
osis (Fig 7).
Further, inflammatory cytokines are generated in this
rocess and play an additional role in this pathology. IL-8
nd TNF- stimulate ultralarge vWF released from endo-
helial cells, and IL-6 significantly inhibits the rate of the
leavage of ultralarge vWF.13 The levels of IL-6, IL-8,
NF- were all markedly reduced after the administration
f GSPE, suggesting that GSPE may contribute to platelet
and ADAMTS13 (a disintegrin and metalloproteinase
t sections of (a, b, c) prethrombosis, (d, e, f) control
SPE) group. b, vWF expression of prethrombotic vein
n, vWF expression in the control group was upregulated
sitive stained. h, vWF expression of in the GSPE group
f ADAMTS13 in the (f) control group was weaker than
shown in the hematoxylin and eosin (HE)-stained slice.
rows point to the postthrombosis endothelium in control
n the GSPE group. Th, Thrombus; vw, vein wall. 100:vWF)
ryosta
ct (G
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have been implicated in leukocytes transmigrating to the site
of endothelial injury and in platelet aggregation.17,20,34 Our
results demonstrate that GSPE may inhibit platelet aggrega-
tion by decreasing CAMs (Figs 6 and 8).
Several studies have reported that grape seed proantho-
cyanidins should be a potent cardioprotective com-
pound.6,35,36 GSPE treatment significantly decreased
TNF-–induced adherence of T cells to human umbilical
vein endothelial cells.6 Shao et al36 suggested that GSPE
protected cardiomyocytes from ischemia and reperfusion
injury by way of protein kinase B-nitric oxide synthase
signaling. The potent inhibitory effect of GSPE on inflam-
mation suggests therapeutic potential of this extract in
inflammatory conditions, oxidative stress, and other pa-
thologies, including thrombovasculitis, diabetic vascular
complication, and rheumatic diseases that are involved in
endothelial dysfunction and injury. Taken together, our
results showed that GSPE inhibited proinflammatory cyto-
kine production and CAM expression, indicating GSPE is a
potential candidate for controlling thrombotic inflamma-
tion and vasculopathy.
CONCLUSIONS
We conclude that GSPE significantly inhibited the
formation of thrombus induced by IVC ligation in a rat
model. It is reasonably speculated that the antithrombotic
properties of GSPE are directly associated with inhibition
of inflammatory cell and thrombus adhesion and platelet
aggregation, endothelial cell proliferation signal transduc-
tion, and endothelial progenitor cell-induced endothelium
regeneration. Thus, GSPE may be a promising candidate
for effective and safe treatment of DVT.
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